Saldua, Fidelia A.
HRN: 23-82-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/28/2025
05/05/2025
IV
4.5
Q8
CAP HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes